China's Draft Cell Therapy Guidelines Draws Concern From Industry

 
• By Brian Yang
CHINA CDE'S SENIOR REVIEWER HUANG HONGYUN AT CHINA RARE DISEASE SUMMIT LAST SEPTEMBER • Source: The Pink Sheet

More from China

More from Asia